A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

Recruiting Phase 2 Interventional Study
Surgery Nerve Injury Imaging
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Prevention
Participants needed
64 (estimated)
Sponsor
Alume Biosciences, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Must be a minimum of 18 years of age * Study participant is planning to proceed with surgery * Willing to provide informed consent * Sexually active patients must be willing to use an acceptable form of contraceptive while participating and 30 days after. * Females of childbea…
Contacts

Barbara Stephens

6145569561

barbara.stephens@alumebiosciences.com

CONTACT